Literature DB >> 29650800

MGUS, lymphoplasmacytic malignancies, and Gaucher disease: the significance of the clinical association.

Neal J Weinreb1,2, Pramod K Mistry3, Barry E Rosenbloom4,5, Madhav V Dhodapkar6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29650800      PMCID： PMC5981170          DOI： 10.1182/blood-2018-02-834689

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  20 in total

1.  The history and accomplishments of the ICGG Gaucher registry.

Authors:  Neal J Weinreb; Paige Kaplan
Journal:  Am J Hematol       Date:  2015-07       Impact factor: 10.047

2.  Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.

Authors:  Atul Mehta; Nadia Belmatoug; Bruno Bembi; Patrick Deegan; Deborah Elstein; Özlem Göker-Alpan; Elena Lukina; Eugen Mengel; Kimitoshi Nakamura; Gregory M Pastores; Jordi Pérez-López; Ida Schwartz; Christine Serratrice; Jeffrey Szer; Ari Zimran; Maja Di Rocco; Zoya Panahloo; David J Kuter; Derralynn Hughes
Journal:  Mol Genet Metab       Date:  2017-08-04       Impact factor: 4.797

3.  Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases.

Authors:  P W Pratt; S Kochwa; S Estren
Journal:  Blood       Date:  1968-05       Impact factor: 22.113

Review 4.  How I manage monoclonal gammopathy of undetermined significance.

Authors:  Ronald S Go; S Vincent Rajkumar
Journal:  Blood       Date:  2017-11-28       Impact factor: 22.113

Review 5.  The association of Gaucher's disease and dysproteinemias.

Authors:  Y Shoenfeld; S Berliner; J Pinkhas; E Beutler
Journal:  Acta Haematol       Date:  1980       Impact factor: 2.195

6.  Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.

Authors:  Shiny Nair; Andrew R Branagan; Jun Liu; Chandra Sekhar Boddupalli; Pramod K Mistry; Madhav V Dhodapkar
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

Review 7.  Benign Bone Conditions That May Be FDG-avid and Mimic Malignancy.

Authors:  Thomas C Kwee; John M H de Klerk; Maarten Nix; Ben G F Heggelman; Stefan V Dubois; Hugo J A Adams
Journal:  Semin Nucl Med       Date:  2017-04-12       Impact factor: 4.446

8.  Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.

Authors:  Pramod K Mistry; Sara Sadan; Ruhua Yang; John Yee; Mei Yang
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

9.  Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy.

Authors:  Elena V Pavlova; Joy Archer; Susan Wang; Nick Dekker; Johannes Mfg Aerts; Stefan Karlsson; Timothy M Cox
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

10.  Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model.

Authors:  Matthew I Bellgard; Kathryn R Napier; Alan H Bittles; Jeffrey Szer; Sue Fletcher; Nikolajs Zeps; Adam A Hunter; Jack Goldblatt
Journal:  Blood Cells Mol Dis       Date:  2017-01-27       Impact factor: 3.039
View more
  4 in total

Review 1.  A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact.

Authors:  Ari Zimran; Rosa Ruchlemer; Shoshana Revel-Vilk
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  Genetic Analysis of Acid β-Glucosidase in Patients with Multiple Myeloma from Central Taiwan: A Small-Cohort Case-Control Study.

Authors:  Wei-De Lin; Fuu-Jen Tsai
Journal:  Biomed Hub       Date:  2021-11-29

Review 3.  Gaucher disease: Basic and translational science needs for more complete therapy and management.

Authors:  Gregory A Grabowski; Armand H M Antommaria; Edwin H Kolodny; Pramod K Mistry
Journal:  Mol Genet Metab       Date:  2020-12-29       Impact factor: 4.797

4.  Patient reported outcome measures in a large cohort of patients with type 1 Gaucher disease.

Authors:  Tama Dinur; Majdolen Istaiti; Dafna Frydman; Michal Becker-Cohen; Jeff Szer; Ari Zimran; Shoshana Revel-Vilk
Journal:  Orphanet J Rare Dis       Date:  2020-10-13       Impact factor: 4.123
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.